𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rehabilitation of persons with central nervous system tumors

✍ Scribed by Steven Kirshblum; Michael W. O'Dell; Chester Ho; Karen Barr

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
127 KB
Volume
92
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of central nervous system sarc
Treatment of central nervous system sarcoidosis with radiotherapy
✍ Dr. Jose M. Bejar; Gerald R. Kerby; Dewey K. Ziegler; Barry W. Festoff πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 244 KB πŸ‘ 1 views

This report documents the twelve-year follow-up of a patient with neurosarcoidosis with multiple progressive central nervous system manifestations. Increased somnolence and seizure activity were associated with proliferation of nodular enhancing brain lesions, as seen on serial computed tomographic

Phase II evaluation of topotecan for ped
Phase II evaluation of topotecan for pediatric central nervous system tumors
✍ Susan M. Blaney; Peter C. Phillips; Roger J. Packer; Richard L. Heideman; Stacey πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 473 KB πŸ‘ 1 views

## BACKGROUND. Topotecan is a topoisomerase I inhibitor that has good penetration across the blood-brain barrier and significant antitumor activity against human brain tumor xenografts. In a Phase I trial in children with refractory cancer, topotecan was well tolerated when administered as a 24-ho

Radiotherapy of central nervous system t
Radiotherapy of central nervous system tumors in young children: Benefits and pitfalls
✍ Skowro?ska-Gardas, Anna πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

Background. The prognosis for young children suffering from brain tumors is, as many authors report, generally poor. The probability of late complications in young children is also high, and their quality of life is significantly worse than that of older children. This study presents the experience